Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
Consistent deregulation of gene expression between human and murine MLL rearrangement leukemias.
复制标题
DOI:
10.1158/0008-5472.can-08-3381
复制
发表时间:
2009-02-01
期刊:
影响因子:
11.2
通讯作者:
Thirman MJ
中科院分区:
文献类型:
--
作者:
Li Z;Luo RT;Mi S;Sun M;Chen P;Bao J;Neilly MB;Jayathilaka N;Johnson DS;Wang L;Lavau C;Zhang Y;Tseng C;Zhang X;Wang J;Yu J;Yang H;Wang SM;Rowley JD;Chen J;Thirman MJ
Important biological and pathological properties are often conserved across species. Although several mouse leukemia models have been well established, the genes deregulated in both human and murine leukemia cells have not been studied systematically. We performed a serial analysis of gene expression (SAGE) analysis on gene expression in both human and murine MLL-ELL or MLL-ENL leukemia cells, and identified 88 genes that appeared to be significantly deregulated in both types of leukemia cells, including 57 genes not reported previously as being deregulated in MLL-associated leukemias. These changes were validated by quantitative PCR. The most up-regulated genes include several HOX genes (e.g., HOX A5, HOXA9 and HOXA10) and MEIS1 that are the typical hallmark of MLL-rearrangement leukemia. The most down-regulated genes include LTF, LCN2, MMP9, S100A8, S100A9, PADI4, TGFBI and CYBB. Notably, the up-regulated genes are enriched in Gene Ontology terms such as “gene expression” and “transcription”, whereas the down-regulated genes are enriched in “signal transduction” and “apoptosis”. We showed that the CpG islands of the down-regulated genes are hypermethylated. We also showed that seven individual microRNAs from the mir-17-92 cluster, which are known to be overexpressed in human MLL-rearrangement leukemias, are also consistently overexpressed in mouse MLL-rearrangement leukemia cells. Nineteen possible targets of these microRNAs were identified and two of them (i.e., APP and RASSF2) were confirmed further by luciferase reporter and mutagenesis assays. The identification and validation of consistent changes of gene expression in human and murine MLL-rearrangement leukemias provides important insights into the genetic base for MLL-associated leukemogenesis.